Skip to main content
Back
Watch Compare

Exousia Bio, Inc.

Data quality: 100%
LMMY
OTC Services Educational Services
$0.30
▼ $0.10 (-25.00%)
Mkt Cap: 22.05 M
Price
$0.30
Mkt Cap
22.05 M
Day Range
$0.26 — $0.30
52-Week Range
$0.06 — $16.00
Volume
5,000
Open $0.26
50D / 200D Avg
$0.39
22.76% below
50D / 200D Avg
$0.32
7.24% below

Quick Summary

Key Takeaways

Earnings declined -150.21% over the past year
ROE of 0.13% is below average
Net margin of 399.42% shows strong profitability
Generating 183,169.0 in free cash flow
P/E of 1522.90 — premium valuation
Cash machine — converts 1265.07% of earnings into free cash flow

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)206.67%
Earnings (1Y)-150.21%
FCF Growth (3Y)N/A

Quality

Return on Equity
0.13%
Above sector avg (-15.95%)
ROICN/A
Net Margin399.42%
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio0.00
Interest CoverageN/A

Valuation

PE (TTM)
1522.90
Above sector avg (-1.17)
P/B Ratio1.01
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (502 peers)
Metric Stock Sector Median
P/E 1522.9 -1.2
P/B 1.0 1.4
ROE % 0.1 -16.0
Net Margin % 399.4 -19.4
Rev Growth 5Y % — 4.0
D/E — 0.4

All Fundamental Metrics
Growth
Revenue Growth (1Y) 206.67% Revenue Growth (3Y) N/A
Earnings Growth (1Y) -150.21% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 3,625.0 Net Income (TTM) 14,479.0
ROE 0.13% ROA 0.13%
Gross Margin -1880.00% Operating Margin N/A
Net Margin 399.42% Free Cash Flow (TTM) 183,169.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.00
Interest Coverage N/A Asset Turnover 0.00
Working Capital -261,023 Tangible Book Value 21.79 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 1522.90 Forward P/E N/A
P/B Ratio 1.01 P/S Ratio 6082.76
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0.83%
Market Cap 22.05 M Enterprise Value 22.05 M
Per Share
EPS (Diluted TTM) 0.00 Revenue / Share 0.00
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 1265.07%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2025 FY2023
Revenue 11,500.0 3,750.0 0.0
Net Income -25,807.0 51,395.0 -56,421.0
EPS (Diluted) 0.00 0.00 0.00
Gross Profit 1,833.0 -3,501.0 0.0
Operating Income — — -56,421.0
EBITDA — — —
R&D Expenses — — —
SG&A Expenses — — —
D&A — — —
Interest Expense — — —
Income Tax 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2025 FY2023
Total Assets 27,453.0 0.0 37,044.0
Total Liabilities 82,348.0 0.0 66,132.0
Shareholders' Equity -54,895.0 0.0 -29,088.0
Total Debt — — —
Cash & Equivalents — — 7,855.0
Current Assets 12,964.0 0.0 7,855.0
Current Liabilities 14,169.0 0.0 3,610.0